150 related articles for article (PubMed ID: 14582224)
1. New monoclonal antibodies for hematologic malignancies (and breast cancer).
Curtis MA
Med Health R I; 2003 Aug; 86(8):256-7. PubMed ID: 14582224
[No Abstract] [Full Text] [Related]
2. Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Ng AP; Worth L; Chen L; Seymour JF; Prince HM; Slavin M; Thursky K
Haematologica; 2005 Dec; 90(12):1672-9. PubMed ID: 16330442
[TBL] [Abstract][Full Text] [Related]
3. Targeted monoclonal antibody-based treatment of hematological malignancies.
Kaspers GJ
Expert Rev Anticancer Ther; 2003 Jun; 3(3):253-5. PubMed ID: 12820769
[No Abstract] [Full Text] [Related]
4. Monoclonal Antibodies.
Geskin LJ
Dermatol Clin; 2015 Oct; 33(4):777-86. PubMed ID: 26433849
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules.
Strom TB; Kelley VR; Murphy JR; Nichols J; Woodworth TG
Annu Rev Med; 1993; 44():343-53. PubMed ID: 8476255
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
Dang NH; Fayad L; McLaughlin P; Romaguara JE; Hagemeister F; Goy A; Neelapu S; Samaniego F; Walker PL; Wang M; Rodriguez MA; Tong AT; Pro B
Br J Haematol; 2007 Aug; 138(4):502-5. PubMed ID: 17608763
[TBL] [Abstract][Full Text] [Related]
7. [Current development of new drugs in malignant lymphoma].
Ogura M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():715-30. PubMed ID: 23134034
[No Abstract] [Full Text] [Related]
8. Molecular biology and targeted therapy of cutaneous T-cell lymphomas.
Klemke CD; Goerdt S
G Ital Dermatol Venereol; 2008 Dec; 143(6):365-74. PubMed ID: 19169209
[TBL] [Abstract][Full Text] [Related]
9. The role of recombinant interleukin-2 in therapy for hematologic malignancies.
Dutcher JP; Wiernik PH
Semin Oncol; 1993 Dec; 20(6 Suppl 9):33-40. PubMed ID: 8284690
[No Abstract] [Full Text] [Related]
10. Alemtuzumab (Campath 1-H).
Schaal AD
Clin J Oncol Nurs; 2005 Oct; 9(5):630-2. PubMed ID: 16235592
[TBL] [Abstract][Full Text] [Related]
11. Recombinant toxins for the treatment of cancer.
Kreitman RJ
Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
[TBL] [Abstract][Full Text] [Related]
12. Novel therapies for chronic lymphocytic leukemia.
Mavromatis BH; Cheson BD
Blood Rev; 2004 Jun; 18(2):137-48. PubMed ID: 15010151
[TBL] [Abstract][Full Text] [Related]
13. Targeting diphtheria toxin to growth factor receptors.
Murphy JR; vanderSpek JC
Semin Cancer Biol; 1995 Oct; 6(5):259-67. PubMed ID: 8562903
[TBL] [Abstract][Full Text] [Related]
14. Alemtuzumab.
Ravandi F; O'Brien S
Expert Rev Anticancer Ther; 2005 Feb; 5(1):39-51. PubMed ID: 15757437
[TBL] [Abstract][Full Text] [Related]
15. [Multiple sclerosis. What about treatment with monoclonal antibodies?].
Marignier R; Confavreux C
Rev Prat; 2010 Mar; 60(3):304-6. PubMed ID: 20402115
[No Abstract] [Full Text] [Related]
16. A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors.
Penichet ML; Dela Cruz JS; Shin SU; Morrison SL
Hum Antibodies; 2001; 10(1):43-9. PubMed ID: 11455061
[TBL] [Abstract][Full Text] [Related]
17. Improving the efficacy of antibody-based cancer therapies.
Carter P
Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803
[TBL] [Abstract][Full Text] [Related]
18. NCCN: New directions in chronic lymphocytic leukemia.
O'Brien S
Cancer Control; 2001; 8(6 Suppl 2):114-7. PubMed ID: 11760553
[No Abstract] [Full Text] [Related]
19. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
[No Abstract] [Full Text] [Related]
20. Monoclonal antibody treatment of solid tumors: a coming of age.
Murray JL
Semin Oncol; 2000 Dec; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
